Cross-disease LC–MS/MS plasma proteomics identifies reproducible shared and disease-enriched biomarker signatures in neurodegenerative disorders
A comparative plasma proteomic analysis using liquid chromatography–tandem mass spectrometry in 264 participants across major neurodegenerative and related diagnostic groups, providing a cross-disease, cross-platform framework for uncovering reproducible proteomic biomarkers and shed light on both overlapping and disti...